GSK bets $2 billion on Bellus cough drug to soothe pipeline fears
Investors are particularly interested in GSK’s future plans, given the pending loss of patent protection in 2027 for dolutegrav..
Headlines
All Posts
Investors are particularly interested in GSK’s future plans, given the pending loss of patent protection in 2027 for dolutegrav..
Headlines
..
Headlines
..
Headlines
..
Headlines
..
Headlines
..
Headlines
The English soccer club’s stock fell to $18.91, its lowest since late November, when the Glazers had started weighing options i..
Investing
“We continue to engage extensively with our shareholders and believe that they recognize that Teck will be in a far better posi..
Headlines
By Martin Coulter and Supantha Mukherjee LONDON/STOCKHOLM (Reuters) -EU lawmakers urged world leaders on Monday to hold a summit to fi..
Technology
..
Headlines